Series Listing



Insights and Updates in the Prevention of HPV-related Cancers in Young and Older Adults

This educational series is designed for pediatricians, PCP's, OB-GYNs, pathologists, ID specialists, and other healthcare practitioners involved in immunization to prevent HPV-related cancers.

Each activity offers:
0.50 AMA PRA Category 1 CreditTM
0.50 CNE Contact Hour

The Now Generation & New Generation of GLP-1 RAs: Reshaping the Care of T2DM

This 4-part webinar series features key members of the American Diabetes Association (ADA)/European Association for the Study of Diabetes and Diabetes Canada guidelines committees who presented the latest data on GLP-1 RAs, including the once weekly formulations, and underscored how this class of antiglycemic agents may alters guidelines recommendations for patients with T2DM. The faculty for this series also includes other preeminent endocrinologists who reviewed the latest clinical trials data from the 2019 ADA meeting on a next-generation oral GLP-1 RA, along with novel agents in development.

Each activity offers:
1.00 Mainpro+ Credit
1.00 AMA PRA Category 1 CreditTM

Treating and Preventing Cancer-Associated VTE: Combining Updated Recommendations and Real-World Data

In this educational series, a distinguished panel of faculty experts provides an in-depth review of optimal management strategies for cancer-associated venous thromboembolism (VTE), including a detailed discussion of new data on the efficacy and safety of novel oral anticoagulants. Updated evidence-based guidelines for both prevention and treatment of VTE will be discussed, as will the latest real-world data and guidance on how best to incorporate this guidance into routine practice.

Each activity offers:
0.50-1.00 AMA PRA Category 1 CreditTM
0.50-1.00 CNE Contact Hour
0.50-1.00 CE for Pharmacists (0.05 CEU)

Contraception Misconceptions: Mythbusting LARC Methods

Optimal contraceptive decision-making calls for careful evaluation to determine which method may be most effective, medically appropriate, and personally acceptable for each individual. Too often, though, contraceptive decisions are made by default, as patients and clinicians alike tend to gravitate to the most familiar methods. As a result, long-acting reversible contraceptive (LARC) methods may be overlooked. Yet LARC methods provide contraceptive efficacy that is comparable with surgical sterilization, are effective for 3 to 10 years (depending on method selection), and can readily be removed when a patient decides to become pregnant. Clinicians should be familiar with LARC methods, including how they differ from each other with respect to important factors (eg, noncontraceptive benefits, mechanisms of action, and adverse effects) that may affect individual patient needs and preferences.

Each activity offers:
0.25-1.00 AMA PRA Category 1 Credit(s)TM

CITY OF HOPE: State of the Art of Cancer Therapeutics

Paradigm Medical Communications, LLC, in collaboration with City of Hope, has launched 4 new continuing medical education (CME) on-demand webinars on 4 different cancer topics: melanoma, immuno-oncology across tumor types, chronic lymphocytic leukemia, and relapsed/refractory multiple myeloma. Each presentation looks at new approaches and categories of treatments to gauge the impact that they are having on important measures of efficacy, including progression-free survival and overall survival. The presentations also provide a glimpse into the future regarding potential treatment regimens that are currently being studied. These programs are given by experts who not only treat the patients who are stricken by these cancers but perform the research in these areas as well. The oncology expert for each 1.00-hour webinar peels back the layers of these complex diseases and reveals the latest new and next-generation treatments through interpretation and discussion of the evidence from relevant studies. So sit down, pick a topic, and learn about the next generation of cancer therapies.

Each activity offers:
1.00 AMA PRA Category 1 CreditTM

Stable CAD and PAD Patients: How Stable Are They?

This educational series is designed for cardiologists and other healthcare providers who care for patients with atherosclerotic disease.

Each activity offers:
0.75-1.00 AMA PRA Category 1 CreditsTM

New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia

This series is designed to meet the educational needs of hematologists/oncologists and other health care professionals who diagnose, treat, and manage patients leukemia. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity.

Each activity offers:
2.00 AMA PRA Category 1 Credit(s)TM
2.00 CE for Nurses
2.00 CE for Pharmacists

Prostatic Urethral Lift: Minimally Invasive Technologies for Treating Lower Urinary Tract Symptoms Due to BPH

According to the National Institutes of Health, an estimated 14 million men in the US have symptoms suggestive of benign prostatic hyperplasia (BPH), which can affect 50% of men aged 51 to 60 years of age, and up to 90% of men over 80 years of age. Common medical therapies include alpha-blockers and 5-alpha-reductase inhibitors and procedures such as transurethral resection of the prostate, transurethral incision of the prostate, and laser-based treatments. Unfortunately, 70% of men will experience side effects with many of these treatment options including ejaculatory dysfunction, erectile dysfunction, urinary incontinence, and strictures. Furthermore, invasive procedures may require a hospital stay, catheterization for several days, and patients undergoing general anesthesia. Prostatic urethral lift may be an alternative option for patients with lower urinary tract symptoms (LUTS) and provides another tool in the urologist's armamentarium for treating BPH.

Each activity offers:
1.00 AMA PRA Category 1 Credit(s)TM

Breast Implant–Associated Anaplastic Large-Cell Lymphoma Series

Recent investigations have uncovered an increasing number of women with breast implants who develop a rare form of non-Hodgkin lymphoma: anaplastic large-cell lymphoma. This breast implant–associated anaplastic large-cell lymphoma (BIA-ALCL) has been linked to women with textured implants rather than those with a smooth surface. While BIA-ALCL is now well known in the plastic surgery and hematology-oncology communities—and the subject of National Comprehensive Cancer Network diagnosis and treatment guidelines—awareness of the lymphoma as well as noncancerous implant-related complications remains largely unknown among primary care clinicians.

Each activity offers:
0.25-1.00 AMA PRA Category 1 CreditTM

On Target in RA Management

An Update on Strategies to Individualize Therapy for Rheumatoid Arthritis

Each activity offers:
0.25 AMA PRA Category 1 CreditTM

Across the Continuum of IBS and CIC: Improving Patient-Provider Communication and Optimizing Treatment

With the ongoing flood of new data on treatment of irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC), clinicians are challenged to keep up to date with evidence-based approaches to CIC and to the various forms of IBS. In this series of case-based audio programs, a noted expert in the management of functional bowel disorders reviews the pathophysiology underlying the current concept of IBS/CIC as a continuum rather than a set of isolated diseases and the biopsychosocial model of brain-gut interaction. He also demonstrates how to avoid common pitfalls in communication between clinicians and patients that often contribute to delayed diagnosis and suboptimal management.

Each activity offers:
0.25 AMA PRA Category 1 CreditTM
0.25 CE for Pharmacists (0.025 CEUs)

Patient-Centric Communication and the IBS/CIC Continuum

Irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC) are common disorders of bowel function, accounting for the largest diagnostic subgroups in gastroenterology practices and representing more than 1 in 10 patients who present in primary care practices. Regrettably, the heavy sociomedical burden and reduced quality of life associated with these disorders are often compounded by late or inaccurate diagnosis and with inadequate or inappropriate management. In fact, in a landmark survey commissioned by the American Gastroenterological Association (AGA), patients reported an average of 4 years to an IBS diagnosis. In this series of programs, these challenges associated with diagnosis are addressed, along with recommendations for evidence-based treatments that address the underlying pathology of the IBS/CIC continuum, as well as practical suggestions for patient-centric care.

Each activity offers
0.50-1.25 AMA PRA Category 1 Credit(s)TM
0.50-1.25 CE for Pharmacists (0.050 CEUs)

Immunotherapy-Induced Rheumatic Diseases: Managing the Intersection of Rheumatology and Oncology

As a result of anticipated exponential growth in the use of ICIs to manage an increasingly long list of cancers, clinicians can expect to encounter increasing numbers of patients with rheumatic irAEs. To meet the educational needs of healthcare providers, this myCME Go video series convenes a leading oncologist and a rheumatologist to discuss the rheumatologic irAEs most commonly observed with ICI agents and how a guideline-driven, stepwise approach to managing these events can best be implemented among members of the collaborative care team.

Each activity offers:
0.50 AMA PRA Category 1 CreditTM
0.50 CNE Contact Hour

A Changing AML Landscape: Adapting Target-Specific Treatments to Individual Patients

For 4 decades, no new agents had been permanently approved for the management of acute myeloid leukemia (AML) in both the newly diagnosed and relapsed/refractory settings. That has changed dramatically in the last 2 years with the approval of 8 new agents and several more in clinical development. This initiative includes activities that provide insight into advances in molecular alterations—FLT3, CD33, IDH-1/2, BCL-2, and others—that may trigger AML in individual patients, and the safety and efficacy of target-specific agents, alone and in combination with other therapies, that inhibit those genetic alterations and have had a significant impact on overall survival.

Each activity offers:
0.75-1.00 AMA PRA Category 1 CreditTM
0.70-1.00 CNE Contact Hour
0.75-1.00 CE for Pharmacists

Getting It Right: Applying Guideline-Directed Medical Therapy

In spite of dramatic improvements in the management of cardiovascular disease in recent decades, morbidity and mortality due to chronic heart failure (HF) remain high. HF is responsible for a shocking five-year mortality of approximately 50%, which is worse than many cancers. Furthermore, gaps between guideline-recommended treatment and clinical practice are causing worse outcomes for patients with HF, who often are sicker than their physicians realize. In this series of programs, a panel of expert faculty address common knowledge and practice gaps in HF management, including emerging best practices for patient-centered care, risk stratification and prognostication, and optimization of medical therapy.

Each activity offers:
0.25-1.25 AMA PRA Category 1 CreditsTM

Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer

This series is intended to improve care of patients with non-small cell lung cancer and head & neck cancer by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Each activity offers:
1.25-2.00 AMA PRA Category 1 CreditsTM
1.25-2.00 CNE Contact Hours

Key Issues in Neuromuscular Blockade and Reversal: Education for the Interprofessional Team

This 3-part series addresses therapeutic options for reversal of neuromuscular blockade (NMB), pharmacoeconomic factors to consider when evaluating options, and a framework for developing a shared model for change that can improve perioperative medication safety and outcomes.

Each activity offers:
0.50-1.50 AMA PRA Category 1 CreditsTM

A Migraine Toolbox: A Practical Approach to Diagnosis and Treatment

The Migraine Toolbox is a free, comprehensive "how to" course in managing migraine. It covers the diagnosis and treatment of this disease. It includes downloadable practical tools - including questionnaires, medication guidelines for clinicians, a patient brochure and other resources. Those with migraine have many symptoms and therefore are seen by a wide range of medical professionals. This educational program will enable primary care physicians, nurses, pharmacists, gastroenterologists, and other non-headache specialists to care for these patients.

Each activity offers:
1.00-2.00 AMA PRA Category 1 CreditsTM
1.00-2.00 CNE Contact Hour
1.00-2.00 CE for Pharmacists
1.00-2.00 CDE Credits

More Than Just a Backache: Addressing the Clinical Challenges of Diagnosing and Treating Axial Spondyloarthritis

This two-part program series has been designed to improve screening of patients with chronic back pain, promote prompt referral to a rheumatologist for diagnostic evaluation, promote the use of validated assessment tools in order to improve early differential diagnosis, increase confidence and competence to select guideline-recommended treatment strategies, and to provide updates on recent therapeutic advances for axial spondyloarthritis (axSpA) and their potential application to patient care.

Each activity offers:
0.75-1.00 AMA PRA Category 1 Credit(s)TM

Emerging Strategies in Novel Targeted Therapies for Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma)

This series is intended to improve care of patients with genitourinary cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma) by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus.

Each activity offers:
1.25-2.00 AMA PRA Category 1 Credit(s)TM
1.25-2.00 CE for Nurses
1.25-2.00 CE for Pharmacists

Engagement with Novel Therapies and Decision Making Through Breast Cancer Education

Module 1: A focused 30-minute module by Donette Vicente, MD, of Duke Cancer Network on current data on the role of CDK4/6 inhibitors in the treatment of advanced breast cancer and the associated toxicity profiles, and strategies for monitoring and managing adverse events.

Module 2: A focused 30-minute module by Kerri A. Dalton MSN, RN, AOCNS, of Duke Cancer Network on patient communications, shared decision making, monitoring and addressing patient compliance with CDK4/6 inhibitors.

Each activity offers:
0.50 AMA PRA Category 1 CreditsTM
0.50 CNE Contact Hours

Emerging Strategies to Delay Progression in Autosomal-Dominant Polycystic Kidney Disease (ADPKD)

Autosomal-dominant polycystic kidney disease (ADPKD), an inherited disorder that affects 1 to 2 individuals per 1000 worldwide, typically develops insidiously, often causing irreversible renal damage years before the patient develops overt symptoms. Until recently, there have been few tools to protect affected individuals from developing kidney failure at a relatively young age. Now, however, new treatments are available, underscoring the importance of early identification and risk stratification in ADPKD.

These 2 activities—a text-based Case Clinic and an Expert Perspectives video—have been developed to inform nephrologists and primary care physicians alike about best practices and emerging therapies for the care of patients with ADPKD in order to help them address crucial unmet clinical needs.

Each activity offers:
Expert Perspective: 1.25 AMA PRA Category 1 CreditsTM
Case Clinic: 1.00 AMA PRA Category 1 CreditTM

Keeping Up With Sleep

The sheer pace of medical research challenges clinicians who try to keep up with the burgeoning volume of literature related to obstructive sleep apnea (OSA), narcolepsy, excessive daytime sleepiness, and other sleep-related disorders. The Keeping Up With Sleep Journal Club selects key articles and shares expert commentary on them, giving learners an educational tool that helps translate emerging knowledge into improvements in clinical care.

Each activity offers:
0.75 AMA PRA Category 1 CreditTM

Insights and Updates in PAH Treatment: A Series Curriculum

This educational series with faculty, Dan Schuller, MD, is designed for primary care physicians, cardiologists, cardiopulmonologists, and other allied healthcare professionals interested in PAH.

Each activity offers:
0.50 AMA PRA Category 1 CreditTM

Recognition of Sleep Quality, Sleep Disorders and their Diagnosis and Management

Sleep is essential for healthy brain function and physical health, whereas sleep deprivation adversely affects physiological functions including those of the CNS, Immune, Respiratory, Digestive, Cardiovascular, and Endocrine systems. The purpose of this series is to examine the enhancement of slow wave sleep, and the effect this may have on brain health and improved memory consolidation.

Each activity offers:
1.00 AMA PRA Category 1 CreditTM
1.00 AANP Contact Hour

is free, fast, and customized just for you!




Already a member?

Sign In Now »

is free, fast, and customized just for you!




Already a member?

Sign In Now »